The D.C. Metropolitan Consortium proposes a WIHS organizational structure that ensures frequent communication between all staff, includes broad and structured inclusion of professional and community input, and organizes Working Group, while still covering all significant areas. The NIAID- WIHS Executive Committee and the Working Groups will have conference calls twice a month. The Consortium consists of five sites, spread throughout the metropolitan area. this geographic base expends outreach potential to a larger proportion of the population and draws in ideas from a variety of providers. The Principal Investigator, Dr. Mary Young, will oversee the Project Manager and the four Site Investigators. Dr. Young, Site Investigators and senior staff will meet monthly for at least the first year to formulate procedures, create time lines and hire staff. A project manager based at the principal site, as well as a nurse practitioner and gynecologist who travel weekly and monthly, respectively, between sites, will add to intersite contact. The Community Advisory Board, stipulated by NIAID as a required part of the structure, is in place with over 30 members and met in January 1993 to offer input toward retention and recruitment plans. The CAB will meet every other month under the direction of Principal Investigator Dr. Mary Young and Dr. Sylvia Silver of George Washington University. In addition, the D.C. Metropolitan consortium proposes and has organized a Professional Advisory Board, comprised of health care professionals with experience in HIV disease. This board will also meet frequently during the first nine months, and occasionally thereafter as necessary.

Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Georgetown University
Department
Type
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Rubin, Leah H; Benning, Lorie; Keating, Sheila M et al. (2018) Variability in C-reactive protein is associated with cognitive impairment in women living with and without HIV: a longitudinal study. J Neurovirol 24:41-51
Belenky, Nadya; Pence, Brian W; Cole, Stephen R et al. (2018) Associations Between Medicare Part D and Out-of-Pocket Spending, HIV Viral Load, Adherence, and ADAP Use in Dual Eligibles With HIV. Med Care 56:47-53
Ascher, Simon B; Scherzer, Rebecca; Estrella, Michelle M et al. (2018) Association of Urinary Biomarkers of Kidney Injury with Estimated GFR Decline in HIV-Infected Individuals following Tenofovir Disoproxil Fumarate Initiation. Clin J Am Soc Nephrol 13:1321-1329
Hanna, David B; Moon, Jee-Young; Haberlen, Sabina A et al. (2018) Carotid artery atherosclerosis is associated with mortality in HIV-positive women and men. AIDS 32:2393-2403
Bekhbat, Mandakh; Mehta, C Christina; Kelly, Sean D et al. (2018) HIV and symptoms of depression are independently associated with impaired glucocorticoid signaling. Psychoneuroendocrinology 96:118-125
Colie, Christine; Michel, Katherine G; Massad, Leslie S et al. (2018) Natural History of Cervical Intraepithelial Neoplasia-2 in HIV-Positive Women of Reproductive Age. J Acquir Immune Defic Syndr 79:573-579
Adimora, Adaora A; Ramirez, Catalina; Benning, Lorie et al. (2018) Cohort Profile: The Women's Interagency HIV Study (WIHS). Int J Epidemiol 47:393-394i
Willis, Sarah J; Cole, Stephen R; Westreich, Daniel et al. (2018) Chronic hepatitis C virus infection and subsequent HIV viral load among women with HIV initiating antiretroviral therapy. AIDS 32:653-661
Belenky, Nadya; Pence, Brian W; Cole, Stephen R et al. (2018) Impact of Medicare Part D on mental health treatment and outcomes for dual eligible beneficiaries with HIV. AIDS Care :1-8
Grover, Surbhi; Desir, Fidel; Jing, Yuezhou et al. (2018) Reduced Cancer Survival Among Adults With HIV and AIDS-Defining Illnesses Despite No Difference in Cancer Stage at Diagnosis. J Acquir Immune Defic Syndr 79:421-429

Showing the most recent 10 out of 633 publications